CareDx director receives quarterly stock grant

Goldberg Michael reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Goldberg Michael reported acquisition or exercise transactions in this Form 4 filing.

CareDx, Inc. director Michael Goldberg received an automatic quarterly grant of 1,981 shares of common stock on 2026-04-02. The shares were granted at no cash cost in lieu of cash non-employee director compensation under the company’s Outside Director Compensation Policy. Following this award, he directly holds 185,942 common shares.

Insider Trade Summary

Grant/Award: 1,981 shares

Grant/Award 1 txn

Insider Goldberg Michael

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,981	$0.00	$0.00

Holdings After Transaction: Common Stock — 185,942 shares (Direct)

Footnotes (1)

1. F1. Represents an automatic quarterly grant of common stock to the Reporting Person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

Key Figures

Stock grant size: 1,981 shares Price per granted share: $0.0000 per share Shares owned after grant: 185,942 shares

3 metrics

Stock grant size 1,981 shares Automatic quarterly grant of common stock on 2026-04-02

Price per granted share $0.0000 per share Equity issued in lieu of cash compensation

Shares owned after grant 185,942 shares Total direct common stock holdings following the award

Key Terms

automatic quarterly grant, non-employee director compensation, Outside Director Compensation Policy, Common Stock

4 terms

automatic quarterly grant financial

"Represents an automatic quarterly grant of common stock to the Reporting Person"

non-employee director compensation financial

"in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy"

Outside Director Compensation Policy financial

"pursuant to the issuer's Outside Director Compensation Policy"

Common Stock financial

"Represents an automatic quarterly grant of common stock to the Reporting Person"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CareDx (CDNA) director Michael Goldberg report?

Michael Goldberg reported receiving 1,981 shares of CareDx common stock as an automatic quarterly grant. The award was made in lieu of cash compensation under the company’s Outside Director Compensation Policy for non-employee directors.

How many CareDx (CDNA) shares does Michael Goldberg hold after this grant?

After the automatic quarterly grant, Michael Goldberg holds 185,942 shares of CareDx common stock directly. This figure reflects his total direct ownership immediately following the 1,981-share stock award reported in the insider filing.

Was cash paid for the CareDx (CDNA) shares granted to Michael Goldberg?

No cash was paid for these shares; the reported price per share is 0.0000. The 1,981-share grant represents stock issued in lieu of cash compensation under CareDx’s Outside Director Compensation Policy for non-employee directors.

What is the purpose of the CareDx (CDNA) stock grant to Michael Goldberg?

The grant represents automatic quarterly common stock issued instead of cash for non-employee director compensation. It is made pursuant to CareDx’s Outside Director Compensation Policy, aligning director compensation partly with company equity rather than solely cash payments.

Is Michael Goldberg’s CareDx (CDNA) stock grant a market purchase or sale?

The transaction is an acquisition coded as a grant or award, not a market purchase or sale. Shares were issued directly to Michael Goldberg as part of his non-employee director compensation rather than through open-market trading.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/03/2026 - 04:02 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Goldberg Michael

(Last) (First) (Middle)

C/O CAREDX, INC.

8000 MARINA BOULEVARD, 4TH FLOOR

(Street)

BRISBANE CALIFORNIA 94005

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CareDx, Inc. [ CDNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/02/2026		A		1,981(1)	A	$0	185,942	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an automatic quarterly grant of common stock to the Reporting Person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy.

	/s/ Jeffrey Adam Novack, Attorney-in-Fact	04/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)